Study | Pts | RT | Dose (Gy) | FU (months) | Tox | Acute GI grade 2/3 | Late GI grade 2/3 | Acute GU grade 2/3 | Late GU grade 2/3 | Ref |
---|
Skala et al. | 690 | 3D/IMRT | ≤ 79.8 | 37# | RTOG | n.a. | 2.5%/0.7% | n.a. | 8.8/0.9 | 22 |
Lips et al. | 331 | IMRT | 76 | 47* | CTC/RTOG1 | 30%/0 | 9%/1% | 47%/3%2 | 21%/4%2 | 23 |
Current study | 39 | IMRT | 80 | 29# | CTC | 3%/0 | 8%/0 | 61%/3% | 26%/3% | |
- Abbreviations: GI = gastrointestinal; GU = genitourinary; Pts = patients; RT = radiotherapy; FU = follow-up; Tox = toxicity score used; Ref = reference; 3D = three-dimensional conformal radiation therapy; IMRT = intensity modulated radiation therapy; RTOG = Radiation Therapy Oncology Group toxicity criteria; n.a. = not applicable; CTC = Common Toxicity Criteria; # median (months); * mean (months); 1 For acute toxicity CTC criteria were used and for late toxicity RTOG criteria. 2 plus 0.3% of patients with grade 4 toxicity.